BETAHISTINE PRESCRIBING INFORMATION PDF


Author information Article notes Copyright and License information Disclaimer Betahistine dihydrochloride (Serc) is an oral preparation of a. PACKAGE LEAFLET: INFORMATION FOR THE USER. Betahistine Dihydrochloride 8 mg Tablets. Betahistine Dihydrochloride 16 mg Tablets prescription. Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière’s disease. It is also commonly Generic Prescription Products. Show.

Author: Meztizshura Akim
Country: Saint Kitts and Nevis
Language: English (Spanish)
Genre: Sex
Published (Last): 20 June 2004
Pages: 95
PDF File Size: 4.2 Mb
ePub File Size: 9.87 Mb
ISBN: 266-4-50964-710-4
Downloads: 6161
Price: Free* [*Free Regsitration Required]
Uploader: Gonris

The therapeutic efficacy of Formoterol can be decreased when used in combination with Betahistine. Find out more here. Based on in-vitro data, no in-vivo inhibition on Cytochrome P enzymes is expected. The therapeutic efficacy of Betahistine can be decreased when used in combination with Butriptyline.

The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Betahistine.

Norepinephrine The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Betahistine.

The therapeutic efficacy of Betahistine can be decreased when used in combination with Loratadine. The mechanism of action of betahistine is known partially. Betahistine has two modes of action. Caroxazone The metabolism of Betahistine can be decreased when combined with Caroxazone.

Enter medicine name or company Start typing to prescribimg search suggestions. Safrazine The metabolism of Betahistine can be decreased when combined with Safrazine. More serious complications convulsion, pulmonary or cardiac complications were observed in cases of intentional overdose of betahistine especially in combination with other overdosed drugs.

The therapeutic efficacy of Betahistine can be decreased when used in combination with Dexchlorpheniramine maleate. Epub Jun 8. Brompheniramine The therapeutic efficacy of Betahistine can be decreased when used in combination with Brompheniramine.

  CHIEF PFCU PDF

Betahistine dihydrochloride 8 mg tablets – Summary of Product Characteristics (SmPC) – (eMC)

The score line is only to facilitate breaking for ease of swallowing betahistime not to divide into equal doses. Celiprolol The therapeutic efficacy of Celiprolol can be decreased when used in combination with Betahistine. Doing btahistine aids in decreasing symptoms of vertigo and balance disorders. Methantheline The therapeutic efficacy of Betahistine can be decreased when used in combination with Methantheline.

No unchanged betahistine has been detected in urine. The therapeutic efficacy of Betahistine can be decreased when used in combination with Thonzylamine. Isoprenaline The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Betahistine.

Levosalbutamol The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Betahistine. Cyclizine The therapeutic efficacy of Betahistine can be decreased when used in combination with Cyclizine. Chlorcyclizine The therapeutic efficacy of Betahistine can be decreased when used in combination with Chlorcyclizine.

Betahistine

Absorption Betahistine is rapidly and completely absorbed after oral administration of the drug in tablets, and peak plasma concentrations of 14 C-labelled betahistine are attained after approximately one hour of oral administration for fasting subjects.

The therapeutic efficacy of Betahistine can be decreased when used in combination betahhistine Pheniramine. Signals betabistine the inhibition of adenylate cyclase and displays high constitutive a Flunarizine The therapeutic efficacy of Betahistine can be decreased when used in combination with Flunarizine.

Methylene blue The metabolism of Betahistine can be decreased when combined with Methylene blue. How serious are recurrent and single attacks? The therapeutic efficacy of Betahistine can be decreased when used in combination with Maprotiline. The therapeutic efficacy of Betahistine can be decreased when used in informxtion with Doxylamine. Maintenance doses are generally in the range 24 – 48 mg daily. The therapeutic efficacy of Betahistine can be decreased when used in combination with Benzatropine.

  INSTITUCIONES ORATORIAS DE QUINTILIANO PDF

The active ingredient is a specific histamine agonist with virtually no H 2 -activity. The increased amounts of histamine released from histaminergic nerve endings stimulates H 1 receptors, thus augmenting the direct agonistic effects of betahistine on these receptors. Metiamide The therapeutic efficacy of Betahistine can be decreased when used in combination with Metiamide. The therapeutic efficacy beetahistine Doxofylline can be decreased when used in combination with Betahistine.

The therapeutic efficacy of Betahistine can be decreased when used in combination with Infodmation. Buclizine Netahistine therapeutic efficacy of Betahistine can be decreased when used in combination with Betahistone.

Niperotidine The therapeutic efficacy of Betahistine can be decreased when used in combination with Niperotidine. Chloropyramine The therapeutic efficacy of Betahistine can be decreased when used in combination with Chloropyramine. Thonzylamine The therapeutic efficacy of Betahistine can be decreased when used in combination with Thonzylamine.

Imipramine The therapeutic efficacy of Betahistine can be decreased when used in combination with Imipramine.